miltefosine has been researched along with B-Cell Lymphoma in 1 studies
miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dummer, R | 1 |
| Krasovec, M | 1 |
| Röger, J | 1 |
| Sindermann, H | 1 |
| Burg, G | 1 |
1 trial available for miltefosine and B-Cell Lymphoma
| Article | Year |
|---|---|
Topical administration of hexadecylphosphocholine in patients with cutaneous lymphomas: results of a phase I/II study.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biopsy; Female; Hu | 1993 |